MIMOSA Diagnostics Inc. – Trademark Portfolio

Entity Type: 03

MIMOSA Diagnostics Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MIMOSA. The owner is based in Toronto, Ontario.

Unit 434

366 Adelaide St East

Toronto, Ontario M5A3X9 , CA

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MIMOSA
MIMOSA
Registered 2023

Trademark Classifications

MIMOSA Diagnostics Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MIMOSA Diagnostics Inc. have?

MIMOSA Diagnostics Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does MIMOSA Diagnostics Inc. file in?

MIMOSA Diagnostics Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are MIMOSA Diagnostics Inc.'s most well-known trademarks?

MIMOSA Diagnostics Inc.'s registered trademark portfolio includes well-known marks such as MIMOSA. These are among 1 currently registered trademark in the portfolio.

What is MIMOSA Diagnostics Inc.'s trademark registration success rate?

MIMOSA Diagnostics Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.